Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bisabolol, a natural monocyclic sesquiterpene alcohol found primarily in chamomile (Matricaria recutita) and candeia tree essential oil, has been traditionally used for its anti-inflammatory and soothing properties. While its traditional use is prominent for skin irritation and inflammatory skin conditions, recent scientific investigations have also explored its potential in pain relief. Several preclinical studies (mostly in animal models) indicate that bisabolol exhibits analgesic effects, likely associated with its anti-inflammatory actions and possible modulation of inflammatory mediators such as prostaglandins and cytokines. For example, bisabolol has been shown to reduce pain behaviors in rodent models of inflammatory pain and to inhibit nitric oxide production, which is linked to pain signaling.

Despite these promising findings, direct clinical evidence in humans is limited. Most of the available data come from laboratory and animal studies, with few high-quality human trials specifically evaluating bisabolol’s efficacy for general pain management. As a result, while the mechanistic rationale and preclinical data support its potential role, the overall evidence rating remains low (2/5), reflecting the need for more rigorous clinical studies to confirm these effects in human populations. In summary, bisabolol is a promising candidate for pain relief based on its anti-inflammatory and analgesic properties, but its use for this indication is not yet robustly validated in human medicine.

More about bisabolol
More about Pain (general remedies for)

Other ingredients used for Pain (general remedies for)

Other health conditions supported by bisabolol

Products containing bisabolol